Powered by machine learning, a new blood test can enable early detection of multiple cancers
Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Three-drug cocktail shows potential to boost CAR-T cancer therapy
Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center have identified a cocktail of three different drugs that can be used to generate more robust immune system CAR-Ts (chimeric antigen receptor-T cells) to fight cancer. This finding may have a significant impact on improving the production of CAR-T cells for clinical use.
What to do if you miss a dose of GLP-1
Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug—better known as GLP-1—for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics.
Next-generation COVID-19 vaccine presents promising results in mice
Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo’s Medical School (FM-USP) in Brazil is safe and efficacious. The vaccine triggered a satisfactory immune response against the pathogen in the mice and protected them from infection. An article describing the results is published in the journal Scientific Reports.
Unexpected twist: Pharma mergers may reduce drug prices
A new study from the University of Iowa finds that many drug prices actually drop after pharmaceutical company mergers, challenging the belief that mergers are the primary cause of rising drug prices in the United States. The study finds the price drops are due to cost savings achieved by merging firms that have overlapping products that treat the same medical condition.
Elon Musk says a third patient got a Neuralink brain implant. The work is part of a booming field
Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines.
Study examines links between opioid epidemic and rural homelessness
A new study led by a Georgia State University researcher finds that the opioid epidemic and rural homelessness are exacerbating each other with devastating consequences.
New book provides recommendations for addressing cancer among Latinos
With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer.
Study finds preschool wheeze diagnosis and treatment need improvement
A study led by Aston University’s Dr. Gemma Heath and Dr. Prasad Nagakumar from Birmingham Children’s Hospital has shown that treatment and diagnosis for preschool wheeze requires more effective evidence-based guidelines. The findings are published in the journal Archives of Disease in Childhood.
Discovery of Semliki Forest virus’s brain entry route opens new avenues for tumor treatment
In a recent study, researchers from Uppsala University have shown that the Semliki Forest virus enters the central nervous system by first entering the cerebrospinal fluid and then binding to a specific cell type before penetrating deeper into the brain. This finding could potentially be used to develop the Semliki Forest virus as an agent for treating brain cancer. The study has been published in Nature Communications.